Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 59.95
-0.30 (-0.50%)
Oct 17, 2025, 5:35 PM CET
BME:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 159.7 million EUR in the quarter ending June 30, 2025, a decrease of -10.36%. This brings the company's revenue in the last twelve months to 749 million, down -3.73% year-over-year. In the year 2024, Laboratorios Farmaceuticos Rovi had annual revenue of 763.75 million, down -7.93%.
Revenue (ttm)
749.00M
Revenue Growth
-3.73%
P/S Ratio
4.09
Revenue / Employee
342.32K
Employees
2,197
Market Cap
3.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | 419.96M | 38.65M | 10.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.45B |
| Almirall | 1.05B |
| Faes Farma | 543.77M |
| Laboratorio Reig Jofre | 336.87M |
| Clínica Baviera | 288.92M |
| Prim, S.A. | 240.68M |
| Atrys Health | 226.24M |
| Pharma Mar | 189.27M |
Laboratorios Farmaceuticos Rovi News
- 19 days ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Acquisition Of An Injectable Drug Product Manufacturing Site In Phoenix, Arizona Call (Transcript) - Seeking Alpha
- 19 days ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Shareholder/Analyst Call Transcript - Seeking Alpha
- 3 months ago - Laboratorios Farmaceuticos Rovi, S.A. 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 months ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q4 2024 Earnings Call Highlights: Navigating ... - GuruFocus
- 8 months ago - Laboratorios Farmaceuticos Rovi, S.A. (LABFF) 2024 Financial Results Earnings Call Transcript - Seeking Alpha